|1.||Laporte, Jocelyn: 15 articles (12/2014 - 11/2005)|
|2.||Bitoun, Marc: 10 articles (12/2014 - 11/2005)|
|3.||Guicheney, Pascale: 9 articles (06/2012 - 11/2005)|
|4.||Romero, Norma B: 8 articles (12/2014 - 11/2005)|
|5.||Mandel, Jean-Louis: 7 articles (12/2014 - 11/2006)|
|6.||Kretz, Christine: 7 articles (03/2014 - 11/2006)|
|7.||Toussaint, Anne: 6 articles (06/2013 - 09/2007)|
|8.||Prudhon, Bernard: 6 articles (06/2012 - 12/2007)|
|9.||Biancalana, Valérie: 5 articles (12/2014 - 09/2007)|
|10.||Böhm, Johann: 5 articles (12/2014 - 01/2010)|
|1.||Congenital Structural Myopathies (Centronuclear Myopathy)
10/01/2015 - "Dynamin-2 mutations associated with centronuclear myopathy are hypermorphic and lead to T-tubule fragmentation."
07/01/2015 - "Taken together, we conclude that the NF90-NF45 complex induces centronuclear myopathy through increased dynamin 2 expression by an NF90-NF45-induced reduction of miR-133a expression in vivo. "
07/01/2015 - "Finally, the level of dynamin 2, a causative gene of centronuclear myopathy and concomitantly a target of miR-133a, was elevated in the skeletal muscle of NF90-NF45 dbTg mice. "
05/01/2015 - "Mutations in the dynamin-2 (DNM2) gene can cause autosomal dominant or sporadic centronuclear myopathy (CNM). "
04/01/2015 - "A novel dynamin-2 gene mutation associated with a late-onset centronuclear myopathy with necklace fibres."
12/01/2014 - "The contribution of endocytosis to cytoplasmic entry and infection was assessed by two strategies: (i) expression of dominant negative dynamin-2 was measured and was found to efficiently block HIV-1 endocytosis but to not affect fusion or productive infection. "
01/01/2013 - "In the case of αvβ8, but not αvβ6-integrin, the portal of entry is located at lipid microdomains and requires dynamin 2. Thus, a major role of αvβ6- or αvβ8-integrin in HSV infection appears to be to function as gH/gL receptors and to promote virus endocytosis. "
10/01/2012 - "Among patients in whom HPV infection was detected, the degrees of dynamin 2 expression were not associated with the type of HPV infection (low-risk vs. high-risk). "
10/01/2012 - "Dynamin 2, which plays a role in endocytosis, is known to be required for HPV infection on host cells. "
01/01/2011 - "Treatment with an endocytosis inhibitor or knockdown of dynamin 2 expression by siRNAs suppressed MLV infections in all examined cells including XC cells. "
|3.||Muscular Diseases (Myopathy)
04/01/2015 - "Nuclear centralisation and internalisation, sarcoplasmic radiating strands and type 1 muscle fibre predominance and hypotrophy characterise dynamin-2 (DNM2) associated centronuclear myopathy, whereas necklace fibres are typically seen in late onset myotubularin-1 (MTM1)-related myopathy. "
06/01/2011 - "Autosomal-dominant centronuclear myopathy (CNM) due to mutations in the dynamin 2 gene (DNM2) is a rare congenital myopathy histopathologically characterized by centrally located nuclei and a radial arrangement of sarcoplasmic strands around the central nuclei. "
01/01/2007 - "These characteristic findings on muscle MRI confirm similar findings reported for CT imaging in dynamin 2 related dominant centronuclear myopathy and may help to differentiate this disorder from central core disease and other myopathies."
04/01/2010 - "Dynamin 2 (DNM2) mutations cause autosomal dominant centronuclear myopathy, a rare form of congenital myopathy, and intermediate and axonal forms of Charcot-Marie-Tooth disease, a peripheral neuropathy. "
11/01/2014 - "Mutations in amphiphysin-2/BIN1, dynamin 2, and myotubularin are associated with centronuclear myopathy (CNM), a muscle disorder characterized by myofibers with atypical central nuclear positioning and abnormal triads. "
|4.||Central Core Myopathy (Central Core Disease)
|5.||Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
07/01/2008 - "The purpose of the study was to prospectively assess magnetic resonance (MR) imaging findings of lower limb musculature in an axonal Charcot-Marie-Tooth disease (CMT2) pedigree due to mutation in the dynamin 2 gene (DNM2). "
01/01/2012 - "Dynamin 2 in Charcot-Marie-Tooth disease."
07/01/2008 - "Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation."
07/17/2007 - "Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease."
12/01/2007 - "This study suggests that the phenotypes of dynamin 2 related centronuclear myopathy and Charcot-Marie-Tooth disease overlap and that DNM2 mutations may alter cerebral function. "
|2.||p38 Mitogen-Activated Protein Kinases
|3.||GTP Phosphohydrolases (GTPases)
|7.||Small Interfering RNA (siRNA)
|9.||N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazide
|1.||Heterologous Transplantation (Xenotransplantation)